- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Synergy Pharmaceuticals Inc+ Add to Watchlist
SGYP:US3.1500 USD 0.1500 4.55%
As of 20:10:00 ET on 03/04/2015.
Company Profile for Synergy Pharmaceuticals Inc (SGYP)
Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead drug candidate is a a guanylyl cyclase C (GC-C) receptor agonist, to treat gastrointestinal disorders, primarily chronic constipation and constipation-predominant irritable bowel syndrome (IBS-C).
Synergy Pharmaceuticals Inc
Key Executives for Synergy Pharmaceuticals Inc (SGYP)
|Gary S JacobChairman/President/CEO||Patrick H GriffinChief Medical Officer|
|Kunwar ShailubhaiExec VP/Chief Scientfic Officer||Bernard F DenoyerSenior VP:Finance/Secretary|